Insiders Dimerix Limited

Equities

Market Closed - Australian S.E. Other stock markets 07:10:46 10/05/2024 BST			5-day change	1st Jan Change
0.33 ^AUD	-1.49%		-8.33%	+60.98%

05-01	Dimerix Secures Pediatric Plan Approval in the UK for Kidney Disease Medication	MT
04-22	Dimerix Posts AU$35.2 Million Cash, AU$3.3 Million Operating Cash Outflows for March Quarter	MT

Dimerix Limited Announces Appointment of Mark Diamond as Director	11-30	CI
Dimerix Appoints Nonexecutive Chair	11-20	MT
Dimerix Appoints Medical Chief	23/10/23	MT
Dimerix Limited Announces Appointment of Dr David Fuller as Chief Medical Officer	22/10/23	CI
Dimerix Secures Conditional US FDA Clearance for Kidney Medication Brand Name	25/09/23	MT
Dimerix Limited Appoints Clinton Snow New Non-Executive Director to the Board, Effective 01 May 2023	01/05/23	CI
Dimerix Non-Executive Chairman Resigns	23/12/22	MT
Dimerix Names New Chief Medical Officer	07/02/22	MT
Dimerix Limited Appoints Dr. Ash Soman as Chief Medical Officer	06/02/22	CI
Dimerix Limited Announces the Resignation of David Franklyn as Non- Executive Director	10/10/19	CI
Dimerix Limited Announces Management Changes	27/08/18	CI
Dimerix Limited Announces Management Changes	30/04/18	CI
Dimerix Limited Appoints David Packham as Chief Medical Officer	26/03/18	CI
Dimerix Limited Appoints Medical Advisory Board	17/10/17	CI
Dimerix Ltd Appoints Kathy Harrison as its Inaugural Full Time Chief Executive Officer	01/08/17	CI
Dimerix Limited Appoints Hugh Alsop as Non-Executive Director	30/04/17	CI
Dimerix Limited Appoints Kathy Harrison as Chief Executive Officer	06/11/16	CI
Dimerix Announces the Resignation of Elizabeth Jazwinska as Director	03/11/16	CI
Dimerix Limited Appoints Liz Jazwinska as Non-Executive Director	16/12/15	CI
Sun Biomedical Announces Executive Changes	23/11/15	CI

No results for this search